Current Evidence Landscape
Balneotherapy research has expanded significantly over the past two decades, with several Cochrane reviews and meta-analyses now available. The strongest evidence base exists for musculoskeletal conditions, particularly arthritis, with over 30 randomised controlled trials examining various protocols and mineral compositions.
Systematic reviews typically include studies ranging from 50 to 200 participants, though sample sizes vary considerably. Most research originates from European spa centres, particularly in Germany, Israel, and Italy, where balneotherapy is integrated into healthcare systems. This geographical concentration provides consistency in treatment protocols but may limit generalisability to other populations and water sources.
The quality of individual studies varies substantially. Earlier trials often lacked adequate control groups or used waiting-list controls rather than active comparators, whilst more recent research has employed sham treatments and standardised outcome measures.
Key Research Findings
A 2015 Cochrane review examining balneotherapy for rheumatoid arthritis found moderate-quality evidence for pain reduction and improved function, with benefits persisting for up to six months post-treatment. Effect sizes were modest but clinically meaningful, particularly when combined with exercise therapy.
For osteoarthritis, multiple meta-analyses demonstrate consistent benefits for pain and stiffness. A comprehensive 2020 systematic review of 17 trials involving over 1,400 participants found significant improvements in pain scores and quality of life measures. The most robust studies used 15-20 minute daily sessions over 2-3 weeks, with water temperatures between 34-40°C.
Emerging evidence suggests promise for fibromyalgia and chronic low back pain. Preliminary trials indicate that balneotherapy may reduce tender point counts and improve sleep quality in fibromyalgia patients, though larger studies are needed to confirm these findings.
Limitations and Research Gaps
The most significant limitation is the difficulty of creating truly blind studies. Participants inevitably know whether they're receiving genuine mineral water treatment, which may inflate perceived benefits. Some studies attempt to address this with different mineral concentrations, but complete blinding remains challenging.
Protocol heterogeneity presents another major issue. Studies vary widely in treatment duration (from single sessions to four-week programmes), water temperature, mineral content, and additional interventions like underwater exercise. This makes it difficult to determine optimal treatment parameters or compare outcomes across studies.
Publication bias likely exists, as negative results from spa centres may be less likely to reach publication. Additionally, most research comes from regions where balneotherapy is culturally accepted and healthcare-funded, potentially limiting applicability to other healthcare contexts.
Mechanism studies remain sparse. Whilst theories about mineral absorption and anti-inflammatory effects are plausible, direct evidence for these pathways in humans is limited.
Evidence-Supported Applications
The evidence most strongly supports balneotherapy for inflammatory joint conditions, particularly rheumatoid arthritis and osteoarthritis of the knee and hand. Benefits appear to require multiple sessions over 2-4 weeks rather than single treatments, with effects lasting 3-6 months.
For psoriasis and other inflammatory skin conditions, several controlled trials show promise, though the evidence base remains smaller than for joint conditions. Dead Sea balneotherapy specifically has shown consistent benefits for psoriasis severity scores.
What remains uncertain is the relative importance of mineral content versus temperature and hydrostatic pressure. Some studies suggest that heated tap water produces similar benefits to mineral-rich thermal springs, challenging assumptions about specific mineral effects.
The evidence does not support balneotherapy as a standalone treatment for serious chronic conditions, but rather as a complementary approach alongside conventional care.
Future Research Priorities
Larger, higher-quality trials with longer follow-up periods are needed to establish optimal treatment protocols. Standardised outcome measures and treatment durations would improve study comparability and meta-analysis quality.
Mechanism studies using inflammatory biomarkers and skin permeability measures could clarify how balneotherapy exerts its effects. This research might identify which patients are most likely to benefit and inform treatment personalisation.
Comparative effectiveness research examining balneotherapy against other non-pharmacological interventions—such as physiotherapy, acupuncture, or standard spa treatments without mineral water—would help position the therapy within broader treatment algorithms.
Cost-effectiveness analyses are particularly relevant given the infrastructure requirements and geographic limitations of natural thermal springs. Understanding the economic value of balneotherapy could inform healthcare policy decisions and treatment accessibility.





